AS

Angappan Sumathi

Active Director Director/Designated Partner DIN 11792216
DIN 11792216 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Angappan Sumathi

Angappan Sumathi is a Director/Designated Partner at Ssentra Lifesciences Private Limited (since 2026).

DIN 11792216
Primary Designation Director/Designated Partner
First Appointment 22 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ssentra Lifesciences Private Limited U86100TZ2026PTC039654
Director/Designated Partner22 Jul 20262026Active

Board colleagues of Angappan Sumathi

Directorship timeline

Open interactive timeline →
Ssentra Lifesciences Private Limited
Premium access

Shareholding and investment profile for Angappan Sumathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Angappan Sumathi

Angappan Sumathi currently holds 1 directorship: Ssentra Lifesciences Private Limited (Director/Designated Partner, since 22 Jul 2026).

Angappan Sumathi was first appointed on 22 Jul 2026 as Director/Designated Partner at Ssentra Lifesciences Private Limited.

The current boards of Angappan Sumathi's companies include Govindaraj Saravanan (Ssentra Lifesciences Private Limited), Ramasamy Sureshkumar (Ssentra Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available